Mankind Pharma Share Price

₹ 2,528.50

-₹9.40 (-0.37%)
1D
Last updated 05 Nov, 2026, 10:34 IST
NSE: MANKIND
|
Pharmaceuticals

Mankind Pharma Share Price Today

As of 5 Nov 2026, Mankind Pharma share price is ₹2,528.50. The stock opened at ₹2,560.00, compared to its previous close of ₹2,537.90. During today's trading session, Mankind Pharma share price moved in the range of ₹2,515.40 to ₹2,561.20, with an average price of ₹2,538.30 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,909.70 and a high of ₹2,642.00. On the performance front, Mankind Pharma share price has increased by 12.41% over the last six months and is up 7.11% on a year-on-year basis.

Share price over the last 1 day fell from 2538.30 to 2527.20, ranging between 2520.50 and 2539.30.
₹2,515.40
0.37% down today
₹2,561.20
1D LOW
1D HIGH

Mankind Pharma Stock Insights

Latest Earning
Op Profit TrendUp by 20.75% QoQ
Latest Earning
Net Profit TrendUp by 24.74% QoQ
Latest Earning
Revenue TrendUp by 8.76% QoQ
Stock Performance
OutperformingBeat Nifty by 7.6 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 0.01%
Shareholding Pattern
DIIDII decreased stake by 5.97%
Shareholding Pattern
FIIFII decreased stake by 0.88%
Mankind Pharma stock performance
Open₹2,560.00
High₹2,561.20
Low₹2,515.40
Prev. close₹2,537.90
Mankind Pharma trading activity
Volume1,04,772
Average traded price₹2,533.94
Last traded time10:34:05 05 Nov
Last traded quantity1
Circuit
L
H
₹2,284.20
₹2,791.60
52-week
L
H
₹1,909.70
₹2,642.00
Mkt Cap Cr
1,02,315.40
P/E
46.23
P/B
5.95
ROA
7.82%
ROE
12.76%
ROCE
14.68%
Quick Ratio
0.74
EV/EBITDA
24.84

Based on fundamentals, this stock's

Performance: 2 out of 5, Poor
Performance
Poor
Mankind Pharma has underperformed the market
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Mankind Pharma appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Mankind Pharma revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,25,150.1638.74.769.61%13.79%18.65%2.3122.17
Divis Laboratories2,64,141.2491.0315.8914.6%15.32%19.56%3.559.98
Torrent Pharmaceuticals1,76,300.5085.729.794.7%11.42%11.37%0.7533.85
Laurus Labs1,25,352.4494.0820.6811.58%22.11%20.91%0.6853.48
Zydus Lifesciences1,18,702.9626.914.568.57%18.59%17.35%0.9116.36
Dr. Reddy's Laboratories1,14,351.2041.442.954.79%7.21%8.58%1.3518.91
Cipla1,12,471.7539.413.186.6%8.18%10.8%2.521.15
Aurobindo Pharma97,756.7126.352.586.34%9.25%11.76%1.1512.4
Lupin92,144.5417.653.8313.91%23.76%24.88%1.429.85
Glenmark Pharma70,608.3839.286.729.03%28.08%32.7%1.2320.09

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Mankind Pharma Company Background

ISIN
INE634S01028
Sector Market Cap
₹ 102,315.40 Cr

Mankind Pharma Limited is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It also offers pet care, crop protection solutions, and veterinary care. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/central nervous system, vitamins, minerals and nutrients, derma, fertility, and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.

Mankind Pharma Financial Highlights

  • Revenue: Mankind Pharma reported revenue of ₹14,636.43 crore in FY26 vs ₹12,744.23 crore in FY25. It showed an increase of 14.85% on a yearly basis.
  • Operating Profit: Mankind Pharma reported an operating profit of ₹2,332.68 crore in FY26 vs ₹2,516.33 crore in FY25. It showed a decrease of 7.30% on a year-on-year basis.
  • Net Profit: Mankind Pharma reported a net profit of ₹1,938.10 crore in FY26 vs ₹2,011.12 crore in FY25. It showed a decrease of 3.63% on a yearly basis.

Mankind Pharma Quarterly Result Highlights

  • Mankind Pharma reported revenue of ₹4,432.71 crore in Sep 2026, compared with ₹4,075.59 crore in Jun 2026, representing an increase of 8.76% on a quarter-on-quarter (QoQ) basis.
  • Mankind Pharma reported an operating profit of ₹929.11 crore in Sep 2026, compared with ₹769.45 crore in Jun 2026, representing an increase of 20.75% on a quarter-on-quarter (QoQ) basis.
  • Mankind Pharma reported a profit of ₹716.12 crore in Sep 2026, compared with ₹574.09 crore in Jun 2026, reflecting an increase of 24.74% on a QoQ basis.
  • The earnings per share (EPS) of Mankind Pharma stood at ₹46.35 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.62%
FII
9.37%
Other DII
4.25%
Retail and other
2.45%
Mutual funds
11.31%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202511.34%
Mar 202610.24%
Jun 20269.45%
Sep 20269.37%

Mankind Pharma Investment Returns

1 day
+2.54%
1 week
+1.92%
1 month
+0.11%
1 year
+7.11%
3 years
+42.97%
5 years
+78.44%

Mankind Pharma Share Price History

Mankind Pharma share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
04 Nov 26
₹2,485.00 / ₹2,537.90
+2.54%
03 Nov 26
₹2,500.00 / ₹2,475.00
-0.25%
02 Nov 26
₹2,505.30 / ₹2,481.20
-0.47%
30 Oct 26
₹2,469.30 / ₹2,492.80
+0.95%
Show more

Mankind Pharma Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹14,277.64₹12,207.44₹10,260.44₹8,749.43
Other Income₹358.79₹536.79₹280.22₹128.57
Total Revenue₹14,636.43₹12,744.23₹10,540.66₹8,878.00
Total Expenses₹12,185.69₹10,240.14₹8,157.93₹7,219.18
Profit Before Tax₹2,332.68₹2,516.33₹2,397.94₹1,671.24
Tax₹394.58₹509.74₹457.15₹361.56
Profit After Tax₹1,938.10₹2,006.59₹1,940.79₹1,309.68
EPS - Basic₹46.35₹49.28₹47.75₹32.00
EPS - Diluted₹46.28₹49.19₹47.68₹32.00

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,332.68₹2,524.78₹2,399.35₹1,671.24
Income before WC changes₹3,609.20₹3,126.57₹2,611.54₹1,969.67
Change in Assets-₹384.14-₹441.41-₹226.35₹222.73
Change in Liabilities₹488.96₹294.97₹208.78-₹56.00
Change in WC₹104.82-₹146.44-₹17.57₹166.73
Cash flow from Operations₹3,121.29₹2,413.38₹2,152.44₹1,813.30
Cash flow from Investing-₹196.42-₹12,682.95-₹2,081.69-₹1,054.13
Cash flow from Financing-₹2,952.69₹10,232.56₹5.27-₹739.73
Total Cash Flow-₹27.82-₹37.01₹76.02₹19.44
Cash (Start of the year)₹403.88₹382.01₹304.82₹283.06
Cash (End of the year)₹391.69₹403.88₹382.01₹304.82

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹21,125.33₹20,771.26₹5,395.03₹5,387.58
Current Assets₹6,954.20₹6,988.27₹6,568.22₹4,327.87
Total Assets₹28,079.53₹27,759.53₹11,963.25₹9,715.45
Current Liabilities₹6,507.25₹5,663.56₹2,119.73₹1,863.14
Net Current Asset₹446.95₹1,324.71₹4,448.49₹2,464.74
Non-Current Liabilities₹5,011.23₹7,527.79₹267.73₹229.02
Equity Capital₹16,561.05₹14,568.18₹9,575.79₹7,623.29
Total Equity & Liabilities₹28,079.53₹27,759.53₹11,963.25₹9,715.45

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹10,421.18₹9,507.41₹8,629.25₹8,127.15
Other Income₹326.10₹493.42₹270.50₹162.78
Total Revenue₹10,747.28₹10,000.83₹8,899.75₹8,289.94
Total Expenses₹8,326.04₹7,854.33₹6,714.55₹6,727.10
Profit Before Tax₹2,315.00₹2,146.50₹2,185.20₹1,562.84
Tax₹277.44₹421.74₹412.57₹314.58
Profit After Tax₹2,037.56₹1,724.76₹1,772.63₹1,248.26
EPS - Basic₹49.37₹44.22₹46.84₹31.16
EPS - Diluted₹49.30₹44.13₹46.77₹31.16

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹2,315.00₹2,230.87₹2,325.72₹1,562.84
Income before WC changes₹3,046.49₹2,703.16₹2,490.46₹1,789.84
Change in Assets-₹138.57-₹186.47-₹583.75₹427.77
Change in Liabilities₹318.93₹304.93₹250.37-₹133.55
Change in WC₹180.36₹118.46-₹333.38₹294.21
Cash flow from Operations₹2,751.99₹2,350.14₹1,736.08₹1,798.99
Cash flow from Investing-₹387.96-₹12,114.46-₹1,665.19-₹1,040.61
Cash flow from Financing-₹2,476.92₹9,816.50-₹4.73-₹710.41
Total Cash Flow-₹112.89₹52.18₹66.16₹47.96
Cash (Start of the year)₹200.68₹211.62₹145.46₹86.17
Cash (End of the year)₹87.66₹200.66₹211.62₹134.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹20,439.48₹19,737.53₹5,886.84₹5,854.21
Current Assets₹4,185.83₹4,720.70₹5,629.55₹3,516.91
Total Assets₹24,625.31₹24,458.23₹11,516.39₹9,371.12
Current Liabilities₹5,473.19₹4,958.88₹1,616.56₹1,419.09
Net Current Asset-₹1,287.36-₹238.18₹4,012.99₹2,097.82
Non-Current Liabilities₹2,755.18₹5,176.63₹197.06₹168.12
Equity Capital₹16,396.94₹14,322.72₹9,702.77₹7,783.91
Total Equity & Liabilities₹24,625.31₹24,458.23₹11,516.39₹9,371.12
* All values are in INR Crore
Mankind Pharma market depth
Bid quantityBid priceAsk priceAsk quantity
12527.625284
112527.22528.525
212527.12528.614
7925272528.71
142526.92528.815
Total bid quantity126
Total ask quantity59
Mankind Pharma technical summary
Bearish indicators4
Neutral indicators3
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
61.35
Neutral
ATR (14)
79.65
Neutral
STOCH(9,6)
96.85
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
34.59
Bearish
UO(9)
56.94
Neutral
ROC(12)
11.53
Bullish
WillR(14)
-3.15
Bearish
Period
Simple value
Exponential vaue
5D
2481.66
2463.66
10D
2399.65
2430.61
20D
2386.42
2408.04
50D
2386.07
2402.52
100D
2432.18
2388.31
Volume trend — traded volume by day
5 Nov1L
4 Nov6L
3 Nov7L
2 Nov4L
30 Oct6L
29 Oct7L
Average5L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Mankind Pharma
Pharmaceuticals
Add Stock
Add Another

Mankind Pharma Returns Calculator

Mankind Pharma Latest News

1 week ago
Mankind Pharma shares surge over 8% on strong Q2 earnings show; further growth potential ahead?
1 week ago
Mankind Pharma Q2 results: Profit rises 39% YoY to ₹711 crore as operating margins improve 300 basis points
2 weeks ago
Stocks to watch, Oct 16: YES Bank, Mankind Pharma, TechM, Wipro, DLF, Shoppers Stop, Punjab National Bank
1 month ago
Mankind, Dr Reddy, Gland Pharma, others lift Nifty Pharma up over 1% as US exempts certain drugs from 100% tariffs
1 month ago
Sun Pharma, Mankind Pharma, Wockhardt, other pharma stocks surge up to 6%, Nifty Pharma up 1.5%; key things to know
2 months ago
Sun Pharma, Laurus Labs, Mankind Pharma, others drag Nifty Pharma down 1.6%; here’s what investors should know
3 months ago
Torrent Pharma, Mankind, Cipla, others lift Nifty Pharma 1.8%; why are pharma stocks rising in weak market?
4 months ago
Cipla, Alkem, Zydus shares gain as US FDA reportedly approaches Indian firms for cancer drug supply
5 months ago
Stocks to watch, June 3: NHPC, IT stocks, Alkem Labs, IndiGo, Canara Bank, Mankind Pharma
5 months ago
Mankind Pharma, Zydus Lifesciences fuel Nifty Pharma to 52-week high; index trades 9.8% higher YTD
Showing news item 1 of 10

Top Gainers

ASHOKLEY Share Price
₹170.31
+16.28 (+10.57%)
FIVESTAR Share Price
₹433.15
+36 (+9.06%)
M&MFIN Share Price
₹292.40
+22.3 (+8.26%)
PRINCEPIPE Share Price
₹320.30
+22.55 (+7.57%)
BALKRISIND Share Price
₹2407.80
+164.1 (+7.31%)
See more

Top Losers

PIIND Share Price
₹1870.10
-316.9 (-14.49%)
CUMMINSIND Share Price
₹4230.60
-495.1 (-10.48%)
APTUS Share Price
₹185.15
-21.13 (-10.24%)
GMMPFAUDLR Share Price
₹1201.80
-118.4 (-8.97%)
OIL Share Price
₹435.10
-22.9 (-5%)
See more

Mankind Pharma Share Price FAQs

Please be aware that Mankind Pharma stock prices are subject to continuous fluctuations due to various factors.